Wang et al. showed that LHFPL3-AS1 was upregulated in EBV-positive radioresistant NPC cells, and siRNA targeting of LHFPL3-AS1 could reverse radioresistance in vitro [107]. Here, LHFPL3 is linked to nasopharyngeal carcinoma.